IVIM Technology, Inc. Logo

IVIM Technology, Inc.

Provides intravital microscopy systems & CRO services for preclinical research and drug discovery.

460470 | KO

Overview

Corporate Details

ISIN(s):
KR7460470008
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노4로 17, 대덕비즈센터 비동 415호(관평동), 대전광역시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IVIM Technology, Inc. is a biotechnology company and a leading global provider of advanced intravital microscopy (IVM) solutions for preclinical research. The company specializes in developing and manufacturing pioneering 'All-in-One' intravital confocal and two-photon microscopy systems. These platforms enable researchers to perform high-resolution, real-time 3D imaging of cellular and molecular dynamics within living organisms, aiming to uncover disease pathophysiology and accelerate the discovery of new treatments. In addition to its product suite, IVIM Technology offers Contract Research Organization (CRO) services, providing its proprietary in vivo imaging technology to support and advance drug development projects. The company's core technology was originally developed at the Korea Advanced Institute of Science and Technology (KAIST).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 10.4 KB
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-11 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 15.8 KB
2025-08-01 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 10.0 KB
2025-06-26 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 15.9 KB
2025-06-16 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.5 KB
2025-05-28 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 11.4 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 72.9 KB
2025-04-23 00:00
Regulatory Filings
단일판매ㆍ공급계약체결
Korean 10.6 KB
2025-04-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.6 KB
2025-04-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 73.0 KB
2025-04-15 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.8 KB
2025-03-26 00:00
AGM Information
정기주주총회결과
Korean 22.0 KB
2025-03-26 00:00
Remuneration Information
주식매수선택권부여에관한신고
Korean 15.9 KB

Automate Your Workflow. Get a real-time feed of all IVIM Technology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IVIM Technology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IVIM Technology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea
153710
ORAGENICS INC Logo
Biotech developing intranasal drugs for concussion and other brain disorders.
United States of America
OGEN
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea
476040
Orum Therapeutics, Inc. Logo
Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.
South Korea
475830
OSR Holdings, Inc. Logo
Acquires biopharma R&D platforms to build a diverse portfolio of healthcare therapies.
United States of America
OSRH
OS Therapies Inc Logo
Developing a cancer vaccine to treat HER2-expressing tumors, primarily Osteosarcoma.
United States of America
OSTX
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom
OBD
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium
OXUR
Pasithea Therapeutics Corp. Logo
Developing innovative therapeutics for CNS disorders (ALS, MS) and RASopathies.
United States of America
KTTA

Talk to a Data Expert

Have a question? We'll get back to you promptly.